Annual CFO
-$116.64 M
-$37.15 M-46.73%
December 31, 2024
Summary
- As of March 12, 2025, GPCR annual cash flow from operations is -$116.64 million, with the most recent change of -$37.15 million (-46.73%) on December 31, 2024.
- During the last 3 years, GPCR annual CFO has fallen by -$84.48 million (-262.67%).
- GPCR annual CFO is now -716.61% below its all-time high of -$14.28 million, reached on December 1, 2020.
Performance
GPCR Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$36.47 M
-$16.77 M-85.15%
December 31, 2024
Summary
- As of March 12, 2025, GPCR quarterly cash flow from operations is -$36.47 million, with the most recent change of -$16.77 million (-85.15%) on December 31, 2024.
- Over the past year, GPCR quarterly CFO has dropped by -$16.77 million (-85.15%).
- GPCR quarterly CFO is now -261.24% below its all-time high of -$10.10 million, reached on June 1, 2022.
Performance
GPCR Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$116.64 M
-$14.74 M-14.46%
December 31, 2024
Summary
- As of March 12, 2025, GPCR TTM cash flow from operations is -$116.64 million, with the most recent change of -$14.74 million (-14.46%) on December 31, 2024.
- Over the past year, GPCR TTM CFO has dropped by -$14.74 million (-14.46%).
- GPCR TTM CFO is now -762.82% below its all-time high of -$13.52 million, reached on March 1, 2022.
Performance
GPCR TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GPCR Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.7% | -85.2% | -14.5% |
| 3 y3 years | -262.7% | -85.2% | -14.5% |
| 5 y5 years | -716.6% | -85.2% | -14.5% |
GPCR Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -262.7% | at low | -261.2% | at low | -762.8% | at low |
| 5 y | 5-year | -716.6% | at low | -261.2% | at low | -762.8% | at low |
| alltime | all time | -716.6% | at low | -261.2% | at low | -762.8% | at low |
Structure Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$116.64 M(+46.7%) | -$36.47 M(+85.1%) | -$116.64 M(+14.5%) |
| Sep 2024 | - | -$19.70 M(-25.4%) | -$101.90 M(-0.8%) |
| Jun 2024 | - | -$26.39 M(-22.6%) | -$102.76 M(+10.2%) |
| Mar 2024 | - | -$34.08 M(+56.8%) | -$93.26 M(+17.3%) |
| Dec 2023 | -$79.49 M | -$21.73 M(+5.7%) | -$79.49 M(+13.9%) |
| Sep 2023 | - | -$20.56 M(+21.7%) | -$69.78 M(+16.9%) |
| Jun 2023 | - | -$16.89 M(-16.8%) | -$59.71 M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$20.31 M(+68.9%) | -$52.91 M(+14.7%) |
| Dec 2022 | -$46.12 M(+43.4%) | -$12.03 M(+14.7%) | -$46.12 M(+35.3%) |
| Sep 2022 | - | -$10.48 M(+3.8%) | -$34.09 M(+44.4%) |
| Jun 2022 | - | -$10.10 M(-25.3%) | -$23.61 M(+74.7%) |
| Mar 2022 | - | -$13.52 M | -$13.52 M |
| Dec 2021 | -$32.16 M(+125.2%) | - | - |
| Dec 2020 | -$14.28 M | - | - |
FAQ
- What is Structure Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Structure Therapeutics?
- What is Structure Therapeutics annual CFO year-on-year change?
- What is Structure Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Structure Therapeutics?
- What is Structure Therapeutics quarterly CFO year-on-year change?
- What is Structure Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Structure Therapeutics?
- What is Structure Therapeutics TTM CFO year-on-year change?
What is Structure Therapeutics annual cash flow from operations?
The current annual CFO of GPCR is -$116.64 M
What is the all time high annual CFO for Structure Therapeutics?
Structure Therapeutics all-time high annual cash flow from operations is -$14.28 M
What is Structure Therapeutics annual CFO year-on-year change?
Over the past year, GPCR annual cash flow from operations has changed by -$37.15 M (-46.73%)
What is Structure Therapeutics quarterly cash flow from operations?
The current quarterly CFO of GPCR is -$36.47 M
What is the all time high quarterly CFO for Structure Therapeutics?
Structure Therapeutics all-time high quarterly cash flow from operations is -$10.10 M
What is Structure Therapeutics quarterly CFO year-on-year change?
Over the past year, GPCR quarterly cash flow from operations has changed by -$16.77 M (-85.15%)
What is Structure Therapeutics TTM cash flow from operations?
The current TTM CFO of GPCR is -$116.64 M
What is the all time high TTM CFO for Structure Therapeutics?
Structure Therapeutics all-time high TTM cash flow from operations is -$13.52 M
What is Structure Therapeutics TTM CFO year-on-year change?
Over the past year, GPCR TTM cash flow from operations has changed by -$14.74 M (-14.46%)